Immunogenicity 624

summary
Sample ID
3942
Response
Negative
Tumor Type
Rectal cancer
Gene Symbol
MIPEP
Transcript ID
ENST00000382172
HLA INFO
DQA*02:01 / DQB*02:02
TCR INFO

No TCR info found!

T cell Tumor cell { DQA*02:01 DQB*02:02
sequence
Full length protein sequence (713 aa)
MLCVG
1
RLGGL
6
GARAA
11
ALPPR
16
RAGRG
21
SLEAG
26
IRARR
31
VSTSW
36
SPVGA
41
AFNVK
46
PQGSR
51
LDLFG
56
ERRGL
61
FGVPE
66
LSAPE
71
GFHIA
76
QEKAL
81
RKTEL
86
LVDRA
91
CSTPP
96
GPQTV
101
LIFDE
106
LSDSL
111
CRVAD
116
LADFV
121
KIAHP
126
EPAFR
131
EAAEE
136
ACRSI
141
GTMVE
146
KLNTN
151
VDLYQ
156
SLQKL
161
LADKK
166
LVDSL
171
DPETR
176
RVAEL
181
FMFDF
186
EISGI
191
HLDKE
196
KRKRA
201
VDLNV
206
KILDL
211
SSTFL
216
MGTNF
221
PNKIE
226
KHLLP
231
EHIRR
236
NFTSA
241
GDHII
246
IDGLH
251
AESPD
256
DLVRE
261
AAYKI
266
FLYPN
271
AGQLK
276
CLEEL
281
LSSRD
286
LLAKL
291
VGYST
296
FSHRA
301
LQGTI
306
AKNPE
311
TVMQF
316
LEKLS
321
DKLSE
326
RTLKD
331
FEMIR
336
GMKMK
341
LNPQN
346
SEVMP
351
WDPPY
356
YSGVI
361
RAERY
366
NIEPS
371
LYCPF
376
FSLGA
381
CMEGL
386
NILLN
391
RLLGI
396
SLYAE
401
QPAKG
406
EVWSE
411
DVRKL
416
AVVHE
421
SEGLL
426
GYIYC
431
DFFQR
436
ADKPH
441
QDCHF
446
TIRGG
451
RLKED
456
GDYQL
461
PVVVL
466
MLNLP
471
RSSRS
476
SPTLL
481
TPSMM
486
ENLFH
491
EMGHA
496
MHSML
501
GRTRY
506
QHVTG
511
TRCPT
516
DFAEV
521
PSILM
526
EYFAN
531
DYRVV
536
NQFAR
541
HYQTG
546
QPLPK
551
NMVSR
556
LCESK
561
KVCAA
566
ADMQL
571
QVFYA
576
TLDQI
581
YHGKH
586
PLRNS
591
TTDIL
596
KETQE
601
KFYGL
606
PYVPN
611
TAWQL
616
RFSHL
621
VGYGA
626
RYYSY
631
LMSRA
636
VASMV
641
WKECF
646
LQDPF
651
NRAAG
656
ERYRR
661
EMLAH
666
GGGRE
671
PMLMV
676
EGMLQ
681
KCPSV
686
DDFVS
691
ALVSD
696
LDLDF
701
ETFLM
706
DSE
711
Mutation Information
DNA mutation:
None
Peptide Range:
618 ~ 642
Mut AA position:
630 (13 in Wild Type peptide)
Alignment
Wild Type:
"WQLRFSHLVGYGARYYSYLMSRAVA
||||||||||||.||||||||||||
Mutant:
WQLRFSHLVGYGGRYYSYLMSRAVA"
reference

Science, 2015

Immunogenicity of somatic mutations in human gastrointestinal cancers

Gene Name (from Reference) MIPEP

clinic trial
Checkpoint Blockade

None

ACT

None

Vaccination

None

Curative Effect

None

experiment
minimal_peptide

None

Antigen Type

TMG RNA

T-cell Source

TILs

APC Type

autologous DCs

Assay

IFNg ELISPOT assay